Abbott Laboratories (Pakistan) Ltd.

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: PK0025701019
PKR
994.67
55.02 (5.86%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Abbott Laboratories (Pakistan) Ltd. stock-summary
stock-summary
Abbott Laboratories (Pakistan) Ltd.
Pharmaceuticals & Biotechnology
Abbott Laboratories (Pakistan) Limited is a Pakistan-based healthcare company. The Company is engaged in the manufacture, import and marketing of research-based pharmaceutical, nutritional, diagnostic, diabetic care, hospital and consumer products. The Company's segments include Pharmaceutical, Nutritional and Others. The Pharmaceutical segment is engaged in the manufacture, import and marketing of research-based pharmaceutical products registered with the Drug Regulatory Authority of Pakistan. The Nutritional segment is engaged in the import and marketing of pediatric nutritional products and medical nutritional products. The Others segment represents the manufacture, import and marketing of diagnostic equipment, diabetes care, molecular devices, their testing kits and general healthcare products. The Company has its presence in various therapeutic areas, including gastroenterology, pain, respiratory, cardio vascular and metabolic, and women's and men's health, among others.
Company Coordinates stock-summary
Company Details
Opposite Radio Pakistan Transmission Hyderabad Road, Landhi. KARACHI None : 75120
stock-summary
Tel: 92 21 35069748
stock-summary
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summary Board of Directorsstock-summary
Management
Designation
Mr. Munir Ahmed Shaikh
Non-Executive Chairman of the Board
Ms. Seema Khan
Director - Regulatory Affairs, Director
Muhammad Anjum Latif Rana
Director
Ms. Ayla Majid
Director
Mr. Mohsin Ali Nathani
Director
Mr. A Nil
Director
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
17,346 Million
(Quarterly Results - Mar 2025)
Net Profit:
1,600 Million
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

PKR 103,392 Million (Large Cap)

stock-summary
P/E

18.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.95%

stock-summary
Debt Equity

-0.31

stock-summary
Return on Equity

23.46%

stock-summary
Price to Book

3.65